Lifeline Biotechnologies, Inc. LLBO OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score

17/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Lifeline Biotechnologies, Inc. (LLBO) reported total assets of $0.00 and total liabilities of $0.00 for fiscal year 2022, resulting in total equity of $0.00.

The company held $0.00 in cash and short-term investments. Total debt stood at $0.00.

Criteria supported by this page:

HEALTH (25/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (28/100) — Total assets $0.00 and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 16/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

17/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

25/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

28/100

→ Income

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Lifeline Biotechnologies, Inc. Balance Sheet History

Metric	FY2022	FY2021	FY2020	FY2019
Total Assets	$0.00	$0.00	$0.00	$0.00
Total Liabilities	$0.00	$0.00	$0.00	$0.00
Total Debt	$0.00	$0.00	$0.00	$0.00
Cash & Investments	$0.00	$0.00	$0.00	$0.00
Total Stockholders Equity	$0.00	$0.00	$0.00	$0.00